Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study

被引:0
|
作者
Yoon Hee Park
Jong Mi Seong
Soyeon Cho
Hye Won Han
Jae Youn Kim
Sook Hee An
Hye Sun Gwak
机构
[1] Ewha Womans University,Division of Life and Pharmaceutical Sciences, College of Pharmacy
[2] Asan Medical Center,Department of Pharmacy
[3] Wonkwang University,College of Pharmacy
来源
Journal of Gastroenterology | 2019年 / 54卷
关键词
Proton pump inhibitor; C; Diarrhea;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1052 / 1060
页数:8
相关论文
共 50 条
  • [41] Trends in Clostridium difficile Infection and Risk Factors for Hospital Acquisition of Clostridium difficile among Children with Cancer
    de Blank, Peter
    Zaoutis, Theoklis
    Fisher, Brian
    Troxel, Andrea
    Kim, Jason
    Aplenc, Richard
    JOURNAL OF PEDIATRICS, 2013, 163 (03) : 699 - +
  • [42] Antimicrobial Use and Risk for Recurrent Clostridium difficile Infection
    Drekonja, Dimitri M.
    Amundson, William H.
    DeCarolis, Douglas D.
    Kuskowski, Michael A.
    Lederle, Frank A.
    Johnson, James R.
    AMERICAN JOURNAL OF MEDICINE, 2011, 124 (11) : 1081.e1 - 1081.e7
  • [43] Association between Proton Pump Inhibitor Therapy and Clostridium difficile Infection: A Contemporary Systematic Review and Meta-Analysis
    Tleyjeh, Imad M.
    Bin Abdulhak, Aref A.
    Riaz, Muhammad
    Alasmari, Faisal A.
    Garbati, Musa A.
    AlGhamdi, Mushabab
    Khan, Abdur Rahman
    Al Tannir, Mohamad
    Erwin, Patricia J.
    Ibrahim, Talal
    AlLehibi, Abed
    Baddour, Larry M.
    Sutton, Alex J.
    PLOS ONE, 2012, 7 (12):
  • [44] Proton Pump Inhibitor Use and Recurrent Clostridium difficile-associated Disease A Case-control Analysis Matched by Propensity Score
    Kim, Yong Gil
    Graham, David Y.
    Jang, Byung Ik
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (05) : 397 - 400
  • [45] Proton Pump Inhibitors Should be Used with Caution in Critically III Patients to Prevent the Risk of Clostridium difficile Infection
    Min, Jung Hwa
    Kim, You Sun
    GUT AND LIVER, 2016, 10 (04) : 493 - 494
  • [46] Proton pump inhibitor use and the risk of fractures among an older adult cohort
    Harding, Barbara N.
    Weiss, Noel S.
    Walker, Rod L.
    Larson, Eric B.
    Dublin, Sascha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (06) : 596 - 603
  • [47] Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics
    Lewis, Paul O.
    Lundberg, Timothy S.
    Tharp, Jennifer L.
    Runnels, Clay W.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (10) : 848 - 854
  • [48] Proton Pump Inhibitor Use Is Associated With a Reduced Risk of Infection with Intestinal Protozoa
    Sheele, Johnathan M.
    WILDERNESS & ENVIRONMENTAL MEDICINE, 2017, 28 (04) : 339 - 341
  • [49] Clostridium difficile infection in an Iranian hospital
    Jalali M.
    Khorvash F.
    Warriner K.
    Weese J.S.
    BMC Research Notes, 5 (1)
  • [50] Intravenous proton pump inhibitor use in hospital practice
    Slattery, Eoin
    Theyventhiran, Ruben
    Cullen, Garret
    Kennedy, Fionnula
    Ridge, Carol
    Nolan, Karen
    Kidney, Rachel
    O'Donoghue, Diarmuid P.
    Mulcahy, Hugh E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (06) : 461 - 464